Product ID: SQMIG35A2399
Report ID:
SQMIG35A2399 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
63 |
Figures:
75
Neurological Biomarkers Market size was valued at USD 5.4 Billion in 2021 and is poised to grow from USD 6.13 Billion in 2022 to USD 17.01 Billion by 2030, at a CAGR of 13.6% during the forecast period (2023-2030).
The global neurological biomarkers market has been experiencing steady growth, driven by the increasing prevalence of neurological disorders and the rising demand for accurate diagnostic tools. One of the key drivers behind the market's growth is the growing burden of neurological disorders, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurodegenerative conditions. The aging global population and lifestyle-related factors have contributed to the escalating incidence of these disorders, creating a significant demand for effective diagnostic tools to aid in early intervention and disease management. Furthermore, the increasing focus on precision medicine and targeted therapies has led to a surge in demand for neurological biomarkers. Biomarkers enable healthcare providers to select suitable therapies based on an individual's unique genetic and molecular profile, optimising treatment outcomes and reducing the risk of adverse effects. However, the neurological biomarkers market faces several challenges.
The complexity of neurological diseases and their multifactorial nature make the discovery and validation of reliable biomarkers a daunting task. Extensive research and clinical studies are required to establish the sensitivity, specificity, and predictive value of biomarkers, which can be time-consuming and expensive. Additionally, regulatory and ethical considerations related to biomarker development and validation pose challenges. Ensuring patient privacy, informed consent, and ethical use of biomarker data are crucial aspects that demand careful attention from researchers and healthcare providers. Moreover, standardisation of biomarker assays and data interpretation remains a challenge. Variability in laboratory techniques and data analysis methods may affect biomarker consistency and comparability across different studies and healthcare facilities.
US Neurological Biomarkers Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2399